Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Test results

19 May 2009 08:00

RNS Number : 4559S
Plant Health Care PLC
19 May 2009
 



19 May 2009

Plant Health Care plc 

("Plant Health Care" or "the Company")

The Journal of the American Society of Horticultural Science recently published the findings of an extensive testing and research progamme carried out on Plant Health Care's harpin product when used with lettuce (J. AMER. SOC. HORT. SCI. 134(1):141-147. 2009.). 

A summary of the findings is set out below.


 

 

Researchers from three US academic institutions (Rutgers University, University of California, Davis and University of Arizona), led by Dr. Jorge M. Fonseca at the University of Arizona's Yuma Agricultural Center, have investigated the effect of a pre-harvest treatment of head lettuce with Plant Health Care's harpin protein which is known to boost plants' growth processes and resistance to disease.

Lettuce plants grown at the three locations were treated, five days before harvest with three different rates of the harpin A/B second generation protein. After processing and bagging the lettuces were cool-stored and their quality evaluated over a period of 20 days.

At the two higher rates, the harpin-treated lettuce from California consistently showed better visual quality and lower microbial population than the control. Similarly in Arizona, for part of the storage period, microbial population was lower and visual quality was higher in lettuce treated with harpin at the two higher rates. Overall results in New Jersey showed no major differences among treatments. 

In additional experiments it was shown that antioxidants increased by 40% in head leaves when plants were treated with the two higher rates of harpin, but no visible changes were observed in outer leaves. Furthermore, phenolic content was higher in all treated lettuce than in the control lettuce after 24 hours. Six days later, the levels fell back to the initial stage. 

Overall, it was shown that a pre-harvest, field application of harpin can improve quality of fresh-cut head lettuce under certain environmental conditions. The results with antioxidant activity and phenolic content suggest that improvement in quality is probably the result of alteration of metabolites' composition.

The study clearly shows the potential for harpin use as a pre-harvest treatment to improve several important health and appearance-related aspects of this important produce crop.

- ends -

Enquiries:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Evolution Securities

Tavistock Communications 

Tim Worlledge / Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300 

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk

About Plant Health Care plc:

Plant Health Care plc is a leading provider of natural products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, Plant Health Care currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company listed on the AIM market of the London Stock Exchange in July 2004. Ticker symbol is PHC.

Plant Health Care's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAKSPFLLNEFE
Date   Source Headline
1st Jun 200911:37 amRNSTotal Voting Rights
1st Jun 20097:00 amRNSEuropean Patent Granted for Harpin
28th May 20095:51 pmRNSAdditional Listing
28th May 20095:23 pmRNSSignificant Shareholding
28th May 20098:47 amRNSHolding(s) in Company
20th May 20099:30 amRNSAdditional Listing
19th May 20098:00 amRNSTest results
18th May 20093:47 pmRNSDirector/PDMR Shareholding
18th May 200910:44 amRNSAdditional Listing
13th May 20091:15 pmRNSDirector/PDMR Shareholding
12th May 200911:53 amRNSEGM Statement
30th Apr 200912:41 pmRNSDirector/PDMR Shareholding
24th Apr 200911:50 amRNSPlacing Announcement
16th Apr 20095:01 pmRNSAnnual Financial Report
15th Apr 20095:20 pmRNSAdditional Listing
2nd Apr 20095:47 pmRNSMonsanto Order
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.